|
The lot number was not provided by the customer, therefore the device history records could not be reviewed, however, inspection procedures require any oscor product pass all in-process and qa final inspection before shipping to the customer.One 6.5f destino twist was returned from the customer without the dilator.There were no other accessories.Traces of blood were found on and inside the sheath.Upon evaluation of the returned device, it was observed that the hub cap was detached from the sheath handle.Evidence of sufficient adhesive was found on the sheath hub and underneath the sheath hub cap.Sheath tip was observed to be round and normal.Sheath valve was observed to be normal with helical cuts.A possible cause of the sheath hub detachment could have been due to manipulation around the sheath hub with the ancillary devices used during procedure.Returned device analysis revealed that the hub cap was detached.There was sufficient adhesive observed under the hub cap and on the handle where the hub cap is seated.Exact root cause for the hub cap detached could not be determined.A possible cause of the sheath hub detachment could have been due to manipulation around the sheath hub with the ancillary devices used during procedure.Lot number for the returned unit was not provided so a dhr review could not be completed.Per procedure (destino steerable guiding sheath in-process and final inspection) cap and seal inspection: register the inspection results into destino steerable guiding sheath sub-assembly qa inspection record.Leak test: perform leak test according to procedure based on available leak tester.The leak test is performed by manufacturing personnel and is observed by quality assurance personnel.Per procedure (non-peelable sheath final assembly) using glue dispensing tip place a ring of glue below the seal around the outer rim of the sheath hub.Place the bonded cap (appropriate color) with properly seated seal over the hub and secure it in the sheath assembly fixture.Allow the sheath to remain in the fixture for at least 2 minutes after securing the last sheath in the fixture.After removal from fixture, ensure there is no excess adhesive.After removal from the fixture, each sheath assembly shall be laid flat on the table for a minimum of 15 minutes before proceeding.Sheath assemblies must remain undisturbed for a minimum of 15 minutes.Visually inspect bonded caps after curing.Gap between bonded cap and hub should not exceed 0.020".Sheath should be free of damages and defects.Use the sideport, located at the handle, to inject contrast solution or flush the steerable sheath.The steerable sheath must be thoroughly flushed with either saline or heparinized saline and free of air prior to use to avoid air embolism to the patient.· aspiration and flushing of the sheath should be performed frequently to help minimize the potential for air embolism.· for injecting or aspirating through the sheath, use the sideport only with stopcock.Prior to infusion, remove all air using the sideport.Based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.In addition, there was no new failure mode identified and the risk remains acceptable.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|